CELESTONE® Oral Solution, for oral administration, contains 0.6 mg betamethasone in each 5 mL.
CELESTONE (Betamethasone) is indicated for the following:
Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness.
Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).
Endocrine Disorders Congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis.
Hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency. Synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance.
Gastrointestinal Diseases To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.
Hematologic Disorders Acquired (autoimmune) hemolytic anemia, Diamond-Blackfan anemia, idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, selected cases of secondary thrombocytopenia.
Miscellaneous Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.
Neoplastic Diseases For the palliative management of leukemias and lymphomas.
Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury.
Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids.
Renal Diseases To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
Respiratory Diseases Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.
Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.
Published Studies Related to Celestone (Betamethasone)
Chinese medicine combined with calcipotriol betamethasone and calcipotriol
ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized
controlled trial. 
BACKGROUND: Psoriasis causes worldwide concern because of its high-prevalence, as
well as its harmful, and incurable characteristics... DISCUSSION: To address the effectual remission of the YXBCM01 granule for PV,
this trial may provide a novel regimen for PV patients if the granule can
decrease relapse rate without more adverse effects.
Calcipotriene plus betamethasone dipropionate topical suspension for the
treatment of mild to moderate psoriasis vulgaris on the body: a randomized,
double-blind, vehicle-controlled trial. 
and limbs... CONCLUSION: The topical suspension containing calcipotriene plus betamethasone
Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin
lesions following sulfur mustard exposure: a randomized double-blind clinical
0.1% cream... CONCLUSION: A. vera/olive oil cream was at least as effective as betamethasone
Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. [2011.06.01]
BACKGROUND: Corticosteroids are a versatile option for the treatment of mild-to-moderate psoriasis due to their availability in a wide range of potencies and formulations. Occlusion of the corticosteroid is a widely accepted procedure to enhance the penetration of the medication, thereby improving its effectiveness. Betamethasone valerate (BMV) is a moderately potent corticosteroid that is available as a cream, ointment, and lotion. A ready-to-use occlusive dressing, which provides a continuous sustained release of BMV, has been developed for the treatment of psoriasis. OBJECTIVE: To evaluate the efficacy and safety of a new BMV 0.1% plaster compared with a BMV 0.1% cream in patients with mild-to-moderate chronic plaque psoriasis... CONCLUSIONS: BMV 0.1% plaster is more efficacious than BMV 0.1% cream in the treatment of patients with mild-to-moderate chronic plaque psoriasis in a clinical setting resembling daily clinical practice.
Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial. [2011.05]
PURPOSE: To compare the efficacy of three different formulations containing Betamethasone Valerate versus placebo in the topical treatment of phimosis. As a secondary goal, we compared the outcomes after 30 and 60 days of treatment... CONCLUSIONS: Betamethasone Valerate 0.1%, 0.2% and 0.2% in combination with Hyaluronidase had equally higher results than placebo in the treatment of phimosis in boys from three to ten years-old. Patients initially with partial or no response can reach complete response after 60 days of treatment.
Clinical Trials Related to Celestone (Betamethasone)
Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone [Completed]
Particle steroid drug such as triamcinolone has been used widely for epidural steroid
injection (ESI) treatment in Korea. However, Korea FDA recently prohibit ESI using
triamcinolone, following the regulation of US FDA. Therefore, dexamethasone and
betamethasone become only candidate drugs for ESI in Korea and the investigators are curious
about the effectiveness and safety of both drugs due to limitation of information about
comparison of two drugs in previous literature. So, this study aims to compare the
effectiveness and safety of both drugs and our hypothesis is that there is no difference of
the effectiveness between dexamethasone and betamethasone at 2 weeks after ESI.
Effect of Betamethasone Gel and Lidocaine Jelly on Sore Throat, Cough and Hoarseness of [Completed]
The aim of this study was to investigate the effect of betamethasone gel and lidocaine jelly
(over tracheal tube cuff) compared with distilled water on the post intubation syndrome
incidence. This study has not been carried out in Iran.
99 patients of either sex undergoing elective surgery were recruited in a single blind
randomized study. The patients, using randomization table, were divided into three groups.
Anesthetics and medications used during surgery were similar for all the patients.
For the all patients, the incidence of postoperative sore throat, cough and hoarseness of
the voice in the different follow-up periods (1, 6 and 24 hours) based on the different
types of medications were obtained.
Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section [Terminated]
This is a randomized, multicenter, double blind, placebo controlled trial of betamethasone
versus a placebo given prior to the mothers at term and near term gestation (>34 and <40
weeks of gestation) who are scheduled to undergo a planned Cesarean section. The study
design is to determine the efficacy and safety of betamethasone in the prevention of
breathing problems commonly seen in this population.
In infants born by elective Cesarean section, it is hypothesized that antenatal
betamethasone treatment will reduce the risk of neonatal intensive care unit (NICU)
admission from 11% to 8% and/or oxygen therapy +/- positive pressure ventilation (PPV) for
>30 minutes from 4. 5% to 2. 5%.
Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) [Completed]
This study attempts to document the therapeutic value of combining loratadine antihistamine
action (no sedative) with anti-inflammatory effects of betamethasone at low doses, which may
facilitate treatment adherence by patients whereas providing an effective and rapid
perennial allergic rhinitis (PAR) symptoms relief.
Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure [Completed]
Glaucoma is one of the leading causes of blindness worldwide and trabeculectomy is the most
commonly performed operation to slow-down the disease progression. In this study, we compare
the effect of topical cyclosporine A and betamethasone eye drops on the postoperative course
and surgical success of trabeculectomy.
Reports of Suspected Celestone (Betamethasone) Side Effects
Maternal Exposure During Pregnancy (4),
Injection Site Necrosis (3),
Product Quality Issue (3),
Rash Maculo-Papular (3),
Body Temperature Increased (2),
Dyspnoea Exertional (2),
Caesarean Section (2), more >>
Page last updated: 2014-11-30